Skip to main content
Clinical Trials/TCTR20210923001
TCTR20210923001
Completed
Not Applicable

Prospective study and cost-effectiveness analysis of the outcomes of advanced pain interventions in Thailand)

Mahidol University0 sites50 target enrollmentSeptember 23, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Mahidol University
Enrollment
50
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 23, 2021
End Date
March 31, 2020
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) The patients were more than 7 years old
  • 2\) The patients suffered from chronic intractable pain from FBSS, PVD or neuropathic pain
  • 3\) The patients reported no satisfactory response to previous treatment defined by a pain score (numeric rating scale or NRS) of at least 5 out of 10 for at least 2 years, despite physical therapy, appropriate regimen of pain medication (gabapentin dose of more than 900 mg/day or pregabalin more than 150 mg/day and two or more other pain medications), other pain interventions or surgery.
  • SCS\+CMM group
  • Any patients who underwent a successful SCS trial and subsequent implantation.

Exclusion Criteria

  • 1\. Refusal to participate in the study
  • 2\. Pain due to cancer 3\. Difficulty of communication or poor literacy of Thai language

Outcomes

Primary Outcomes

Not specified

Similar Trials